Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 1
2022 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Extensive aplasia cutis congenita of the trunk.
Höttler A, Forchhammer S, Mentzel T, Kreutzer KB, Wiechers C, Scheu A. Höttler A, et al. Among authors: kreutzer kb. Arch Dis Child Fetal Neonatal Ed. 2024 Aug 22:fetalneonatal-2024-327475. doi: 10.1136/archdischild-2024-327475. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 39174308 No abstract available.
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
Hansen ML, Pellicer A, Gluud C, Dempsey E, Mintzer J, Hyttel-Sorensen S, Heuchan AM, Hagmann C, Dimitriou G, Pichler G, Naulaers G, Cheng G, Vilan A, Tkaczyk J, Kreutzer KB, Fumagalli M, Claris O, Fredly S, Szczapa T, Lange T, Jakobsen JC, Greisen G. Hansen ML, et al. Among authors: kreutzer kb. Trials. 2019 Dec 19;20(1):746. doi: 10.1186/s13063-019-3756-y. Trials. 2019. PMID: 31856902 Free PMC article.
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
Hansen ML, Pellicer A, Gluud C, Dempsey E, Mintzer J, Hyttel-Sørensen S, Heuchan AM, Hagmann C, Ergenekon E, Dimitriou G, Pichler G, Naulaers G, Cheng G, Guimarães H, Tkaczyk J, Kreutzer KB, Fumagalli M, Claris O, Lemmers P, Fredly S, Szczapa T, Austin T, Jakobsen JC, Greisen G. Hansen ML, et al. Among authors: kreutzer kb. Trials. 2019 Dec 30;20(1):811. doi: 10.1186/s13063-019-3955-6. Trials. 2019. PMID: 31888764 Free PMC article.